Although a large number of drugs are available for the treatment of type 2 diabetes mellitus
(T2DM), many patients do not achieve adequate disease control despite adhering to …

Membrane type1-matrix metalloproteinase (MT1-MMP) is a member of metalloproteinases
that is tethered to the transmembrane. Its major function in cancer progression is to directly …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic. Angiotensin-converting enzyme 2 (ACE2) is an entry receptor for SARS-CoV-2 …

Obesity, a global health challenge, is a major risk factor for multiple life-threatening
diseases, including diabetes, fatty liver, and cancer. There is an ongoing need to identify …

Introduction—The purpose of this study was to determine the relative impact of modifiable
and non-modifiable risk factors in the development of gestational diabetes mellitus (GDM) …

Obesity is one of the predominant risk factors for type 2 diabetes. Despite all the modern
advances in medicine, an effective drug treatment for obesity without overt side effects has …

β‐Aminoisobutyric acid (BAIBA) is secreted by skeletal muscle and promotes insulin
sensitivity, fat oxidation, and anti‐inflammation. While BAIBA is purportedly lower in …

Background Conditions in utero influence intrauterine and postnatal infant growth and a few
studies indicate that maternal inflammation and insulin resistance might affect birth and …

Strategies to develop cancer therapies using inhibitors that target matrix metalloproteinases
(MMPs), particularly membrane type‐1 MMP (MT1‐MMP), have failed. This is predominantly …

Background To assess the relationship between novel insulin resistance (IR) indices and
the presence and severity of diabetic retinopathy (DR) in patients with type 2 diabetes …